ELTX Elicio Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$1.92
· of 52w range
· above low
· to high
$1.7152w low
$16.0052w high
Market Cap (MRQ)
$42M
P/E
-3.1
EPS
$-2.58
your badges
52W Range
$2–$16
Analyst Rating
BUY
Price Target
$14
P/E
-3.1
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ELTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.92
Market Cap (MRQ)
$42M
P/E
-3.1
EPS
$-2.58
Debt/Equity (MRQ)
1.2
52W Range
$2–$16
ELTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 2, 2023 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2020-12-31 → 2022-12-31
EPS$-2.582020-12-31 → 2025-12-31
Free Cash Flow·2021-12-31 → 2024-12-31
Net margin·2021-12-31 → 2021-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ELTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -3.15Y avg ≈-4.1 | ≈-4.1 | · | · | |
| P/B (MRQ) | 5.3 | · | 1.1 | Overvalued | |
| Price / Tangible Book | 86.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ELTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 1.2 | · | · | · | |
| Current Ratio (MRQ) | 2.8 | · | 2.9 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 1.2 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-3.1%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-0.43 | $-0.55 | 21.5% |
| March 31, 2026 | May 20, 2026 | $-0.65 | $-0.47 | -37.0% |
| Dec. 31, 2025 | $-0.45 | $-0.45 | 0.86% | |
| Sept. 30, 2025 | $-0.60 | $-0.56 | -7.0% | |
| June 30, 2025 | $-0.66 | $-0.70 | 5.5% | |
| March 31, 2025 | $-0.87 | $-0.85 | -2.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $2M | $28M | $3M | |
| Cost of Revenue | · | · | · | $0 | $433.0K | $1M | |
| R&D Expense | $25M | $34M | $24M | $18M | $49M | $39M | |
| SG&A Expense | $13M | $11M | $12M | $6M | $18M | $18M | |
| Operating Expenses | $38M | $45M | $36M | $24M | $68M | $58M | |
| Operating Income | $-38M | $-45M | $-36M | $-24M | $-39M | $-55M | |
| Interest Expense | · | · | $1M | $4M | · | · | |
| Other Non-op | $-2M | $-7M | $550.0K | $-4M | $-15M | $-25M | |
| Pretax Income | $-40M | $-52M | · | $-39M | $-55M | $-80M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-40M | $-52M | $-35M | $-28M | $-55M | $-80M | |
| EPS (Basic) | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 | |
| EPS (Diluted) | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 | |
| Shares (Basic) | 15,312,751 | 12,202,996 | 5,056,225 | 315,998 | 28,244,825 | 14,762,120 | |
| Shares (Diluted) | 15,312,751 | 12,202,996 | 5,056,225 | 315,998 | 28,244,825 | 14,762,120 | |
| EBITDA | · | $-45M | · | · | $-39M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $18M | $13M | $6M | $89M | $35M | |
| Receivables | · | · | · | $0 | · | · | |
| Prepaid Expense | $748.0K | $2M | $3M | $3M | $2M | $8M | |
| Other Current Assets | · | · | · | $246.0K | $498.0K | $360.0K | |
| Current Assets | $19M | $21M | $16M | $11M | $91M | $42M | |
| PP&E (Net) | $295.0K | $483.0K | $717.0K | $1M | $451.0K | $156.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $968.0K | $582.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $517.0K | $426.0K | |
| Other Non-current Assets | · | · | · | $61.0K | $106.0K | $0 | |
| Total Assets | $26M | $28M | $27M | $23M | $97M | $47M | |
| Accounts Payable | $672.0K | $1M | $4M | $3M | $5M | $6M | |
| Accrued Liabilities | $6M | $8M | $4M | $2M | $3M | $7M | |
| Current Liabilities | $8M | $12M | $10M | $7M | $11M | $107M | |
| Capital Leases | $4M | $5M | $6M | $7M | $3M | $4M | |
| Other Non-current Liabilities | · | · | · | · | $0 | · | |
| Total Liabilities | $24M | $39M | $16M | $14M | $15M | $138M | |
| Long-term Debt | $10M | · | · | · | · | · | |
| Total Debt | · | · | · | · | $0 | · | |
| Common Stock | $178.0K | $110.0K | $96.0K | $3.0K | $300.0K | $156.0K | |
| Paid-in Capital | $235M | $183M | $154M | $5M | $296M | $72M | |
| Retained Earnings | $-234M | $-194M | $-142M | $-107M | $-215M | $-161M | |
| Treasury Stock | $150.0K | $150.0K | $150.0K | $0 | $0 | $2M | |
| AOCI | $-127.0K | $-175.0K | $-197.0K | $0 | $-103.0K | $-333.0K | |
| Stockholders' Equity | $2M | $-11M | $11M | $-102M | $-75M | $-90M | |
| Liabilities + Equity | $26M | $28M | $27M | $23M | $97M | $47M | |
| Shares Outstanding | 17,800,307 | 11,043,837 | 9,618,178 | 320,281 | 310,200 | 15,632,809 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $1M | $1M | $579.0K | $12M | $5M | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | $9M | · | · | |
| Operating Cash Flow | $-37M | $-37M | $-33M | $-22M | $-53M | $-23M | |
| CapEx | $16.0K | $87.0K | $66.0K | $654.0K | $382.0K | $41.0K | |
| Investing Cash Flow | $-16.0K | $-84.0K | $-32.0K | $-654.0K | $-382.0K | $-41.0K | |
| Stock Issued | $16M | $5M | $7M | · | $107M | $-522.0K | |
| Net Stock Activity | · | $5M | · | · | $107M | · | |
| Financing Cash Flow | $37M | $42M | $39M | $21M | $107M | $52M | |
| Net Change in Cash | $-225.0K | $5M | $6M | $-2M | $54M | $29M | |
| Free Cash Flow | · | $-37M | · | · | $-53M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -138.8% | · | |
| Net Margin | · | · | · | · | -192.8% | · | |
| Pretax Margin | · | · | · | · | -192.8% | · | |
| EBITDA Margin | · | · | · | · | -138.8% | · | |
| ROA | · | -187.6% | · | · | -75.9% | · | |
| ROE | · | 342.6% | · | · | -74.8% | · | |
| ROIC | · | · | · | · | -48.2% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.8 | · | · | 8.1 | · | |
| Quick Ratio | · | 1.5 | · | · | 7.9 | · | |
| Debt / Equity | · | · | · | · | 0.0 | · | |
| LT Debt / Equity | · | · | · | · | 0.0 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.4 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $-1.03 | · | · | $2.72 | · | |
| Revenue / Share | · | · | · | · | $1.00 | · | |
| Cash Flow / Share | · | $-3.04 | · | · | $-1.86 | · | |
| Cash / Share | · | $1.60 | · | · | $2.96 | · | |
| EPS (TTM) | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -91.9% | 883.1% | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $28M | $3M | |
| Net Income TTM | $-40M | $-52M | $-35M | $-28M | $-55M | $-80M | |
| Market Cap | · | $56M | · | · | $869M | · | |
| Enterprise Value | · | · | · | · | $780M | · | |
| P/E | -3.1 | -1.2 | -1.2 | -0.1 | -15.0 | · | |
| P/S | · | 24.4 | · | · | 30.7 | · | |
| P/B | · | -5.0 | · | · | 10.7 | · | |
| P / Tangible Book | 86.6 | · | 7.0 | · | · | · | |
| P / Cash Flow | · | -1.5 | · | · | -16.5 | · | |
| P / FCF | · | -1.5 | · | · | -16.4 | · | |
| EV / EBITDA | · | · | · | · | -19.8 | · | |
| EV / FCF | · | · | · | · | -14.7 | · | |
| EV / Revenue | · | · | · | · | 27.6 | · | |
| Earnings Yield | -32.4% | -83.3% | -83.5% | -1099.4% | -6.7% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| R&D Expense | $7M | $7M | $5M | $5M | $7M | $8M | $11M | $7M | $8M | $8M | $6M | $7M | $5M | $5M | $-3M | $5M | |
| SG&A Expense | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $2M | $-1M | $1M | |
| Operating Expenses | $10M | $11M | $9M | $8M | $10M | $11M | $13M | $10M | $11M | $10M | $9M | $11M | $8M | $8M | $-4M | $6M | |
| Operating Income | $-10M | $-11M | $-9M | $-8M | $-10M | $-11M | $-13M | $-10M | $-11M | $-10M | $-9M | $-11M | $-8M | $-8M | $3M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $36.0K | · | $1.0K | $714.0K | $342.0K | $92.0K | $1M | |
| Interest Income | $138.0K | $157.0K | · | $199.0K | $168.0K | $210.0K | · | $185.0K | $137.0K | · | · | $246.0K | $39.0K | · | · | · | |
| Other Non-op | $2M | $-1M | $1M | $-2M | $-470.0K | $-473.0K | $-527.0K | $-8M | $4M | $-2M | $443.0K | $113.0K | $218.0K | $-224.0K | $-2M | $-1M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-12M | $-8M | $-10M | $-11M | $-11M | $-14M | $-19M | $-7M | $-12M | $-9M | $-11M | $-8M | $-8M | $-7M | $-7M | |
| EPS (Basic) | $-0.43 | $-0.65 | $-0.45 | $-0.60 | $-0.66 | $-0.87 | $-1.07 | $-1.39 | $-0.64 | $-1.15 | $21.69 | $-1.27 | $-2.61 | $-24.77 | $-42.92 | $-22.67 | |
| EPS (Diluted) | $-0.43 | $-0.65 | $-0.45 | $-0.60 | $-0.66 | $-0.87 | $-1.07 | $-1.39 | $-0.64 | $-1.15 | $21.69 | $-1.27 | $-2.61 | $-24.77 | $-42.92 | $-22.67 | |
| Shares (Basic) | 19,244,679 | 18,211,745 | · | 16,692,476 | 16,059,423 | 12,950,574 | · | 13,582,345 | 11,284,853 | 10,273,925 | · | 8,376,384 | 2,893,244 | 324,106 | · | 317,512 | |
| Shares (Diluted) | 19,244,679 | 18,211,745 | · | 16,692,476 | 16,059,423 | 12,950,574 | · | 13,582,345 | 11,284,853 | 10,273,925 | · | 8,376,384 | 2,893,244 | 324,106 | · | 317,512 | |
| EBITDA | $-10M | $-11M | · | $-8M | $-10M | $-11M | · | $-10M | $-11M | $-10M | · | $-11M | $-8M | $-5M | · | $-9M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $15M | $19M | $21M | $22M | $18M | $18M | $26M | $3M | $12M | $13M | $15M | $22M | $29M | $6M | $55M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | $10M | · | · | |
| Prepaid Expense | $2M | $1M | $748.0K | $854.0K | $510.0K | $2M | $2M | $3M | $3M | $2M | $3M | $3M | $5M | $2M | $3M | $2M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $405.0K | · | $326.0K | |
| Current Assets | $25M | $16M | $19M | $21M | $23M | $21M | $21M | $31M | $7M | $14M | $16M | $20M | $26M | $41M | $11M | $57M | |
| PP&E (Net) | $213.0K | $249.0K | $295.0K | $328.0K | $377.0K | $430.0K | $483.0K | $523.0K | $597.0K | $635.0K | $717.0K | $772.0K | $919.0K | $0 | $1M | $304.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $0 | $2M | $968.0K | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $0 | $1M | $664.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $864.0K | · | $75.0K | |
| Total Assets | $31M | $23M | $26M | $28M | $30M | $28M | $28M | $38M | $16M | $24M | $27M | $31M | $38M | $42M | $23M | $61M | |
| Accounts Payable | $839.0K | $272.0K | $672.0K | $321.0K | $4M | $4M | $1M | $2M | $1M | $1M | $4M | $4M | $4M | $692.0K | $3M | $2M | |
| Accrued Liabilities | $7M | $6M | $6M | $5M | $5M | $6M | $8M | $5M | $5M | $3M | $4M | $4M | $2M | $1M | $2M | $5M | |
| Current Liabilities | $9M | $7M | $8M | $7M | $10M | $11M | $12M | $9M | $8M | $6M | $10M | $11M | $8M | $2M | $7M | $8M | |
| Capital Leases | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $70.0K | $7M | $3M | |
| Total Liabilities | $23M | $24M | $24M | $24M | $28M | $19M | $39M | $57M | $17M | $20M | $16M | $18M | $14M | $2M | $14M | $11M | |
| Long-term Debt | · | · | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $10M | $9M | · | $10M | $9M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $219.0K | $186.0K | $178.0K | $173.0K | $163.0K | $160.0K | $110.0K | $108.0K | $103.0K | $102.0K | $96.0K | $84.0K | $84.0K | $301.0K | $3.0K | $301.0K | |
| Paid-in Capital | $262M | $244M | $235M | $230M | $218M | $214M | $183M | $161M | $160M | $159M | $154M | $147M | $146M | $298M | $5M | $297M | |
| Retained Earnings | $-254M | $-245M | $-234M | $-226M | $-216M | $-205M | $-194M | $-180M | $-161M | $-154M | $-142M | $-133M | $-123M | $-258M | $-107M | $-248M | |
| Treasury Stock | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | · | $0 | · | |
| AOCI | $-126.0K | $-122.0K | $-127.0K | $-31.0K | $-70.0K | $-144.0K | $-175.0K | $-202.0K | $-238.0K | $-270.0K | $-197.0K | $-25.0K | $-2.0K | $165.0K | $0 | $302.0K | |
| Stockholders' Equity | $8M | $-1M | $2M | $4M | $2M | $9M | $-11M | $-19M | $-2M | $5M | $11M | $13M | $24M | $40M | $-102M | $50M | |
| Liabilities + Equity | $31M | $23M | $26M | $28M | $30M | $28M | $28M | $38M | $16M | $24M | $27M | $31M | $38M | $42M | $23M | $61M | |
| Shares Outstanding | 21,901,569 | 18,639,895 | 17,800,307 | 17,258,652 | 16,262,932 | 15,968,736 | 11,029,382 | 10,784,377 | 10,258,873 | 10,219,989 | 9,603,723 | 8,378,361 | 8,370,268 | 30,114,190 | 320,281 | 30,113,582 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $935.0K | $868.0K | $772.0K | $698.0K | $710.0K | $517.0K | $464.0K | $314.0K | $350.0K | $324.0K | $337.0K | $339.0K | $151.0K | $224.0K | $199.0K | $-1M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Operating Cash Flow | $-8M | $-12M | $-7M | $-11M | $-9M | $-10M | $-9M | $-7M | $-9M | $-12M | $-10M | $-5M | $-10M | $-8M | $-7M | $11M | |
| CapEx | · | · | $16.0K | $0 | · | · | $45.0K | $0 | $42.0K | $0 | $0 | $45.0K | $4.0K | $17.0K | $95.0K | $559.0K | |
| Investing Cash Flow | · | · | $-16.0K | $0 | $0 | $0 | $-45.0K | $0 | $-42.0K | $3.0K | $0 | $-45.0K | $10M | $-17.0K | $-95.0K | $-559.0K | |
| Stock Issued | · | · | · | · | $2M | $835.0K | $-858.0K | $48.0K | $303.0K | $5M | $7M | $0 | $0 | $0 | · | $0 | |
| Net Stock Activity | · | · | · | · | · | $835.0K | · | · | · | $5M | · | · | · | · | · | · | |
| Financing Cash Flow | $17M | $8M | $5M | $10M | $12M | $10M | $227.0K | $31M | $316.0K | $11M | $7M | $60.0K | $35M | $10M | $11M | $10M | |
| Net Change in Cash | $8M | $-4M | $-2M | $-1M | $3M | $240.0K | $-9M | $24M | $-9M | $-1M | $-3M | $-5M | $35M | $2M | $4M | $20M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-12M | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -27.0% | -46.5% | · | -30.2% | -46.7% | -42.6% | · | -54.3% | -27.1% | -35.7% | · | -23.1% | -13.9% | -7.4% | · | -10.5% | |
| ROE | -168.2% | -316.7% | · | 132.9% | -11605.5% | -162.8% | · | 661.0% | -66.0% | -53.1% | · | -33.6% | -18.1% | -8.5% | · | -15.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 2.2 | · | 3.3 | 2.3 | 1.8 | · | 3.4 | 0.9 | 2.4 | · | 1.7 | 3.5 | 20.0 | · | 6.9 | |
| Quick Ratio | 2.6 | 2.1 | · | 3.2 | 2.2 | 1.6 | · | 2.9 | 0.5 | 2.0 | · | 1.3 | 2.9 | 19.2 | · | 6.7 | |
| Debt / Equity | 1.2 | -6.6 | · | 2.5 | 5.1 | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 1.2 | -6.6 | · | 2.5 | 5.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -284.5 | · | -10771.0 | -10.9 | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.36 | $-0.08 | · | $0.22 | $0.11 | $0.56 | · | $-1.76 | $-0.16 | $0.48 | · | $1.59 | $2.81 | $1.32 | · | $1.67 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.64 | · | · | · | $-0.78 | · | · | · | $-1.18 | · | · | · | $-0.27 | · | · | |
| Cash / Share | $1.07 | $0.80 | · | $1.19 | $1.36 | $1.15 | · | $2.41 | $0.33 | $1.16 | · | $1.77 | $2.59 | $0.97 | · | $1.83 | |
| EPS (TTM) | $-2.13 | $-2.36 | · | $-3.20 | $-3.99 | $-3.97 | · | $18.51 | $18.63 | $16.66 | · | $-71.57 | $-92.97 | $-113.56 | · | $-45.61 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $28M | |
| Net Income TTM | $-38M | $-40M | · | $-46M | $-55M | $-51M | · | $-47M | $-39M | $-39M | · | $-33M | $-29M | $-29M | · | $-7M | |
| Market Cap | $86M | $199M | · | $189M | $126M | $98M | · | $54M | $42M | $78M | · | $71M | $80M | $175M | · | $277M | |
| Enterprise Value | $72M | $194M | · | $178M | $113M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.8 | -4.5 | · | -3.4 | -1.9 | -1.6 | · | 0.3 | 0.2 | 0.5 | · | -0.1 | -0.1 | -0.1 | · | -0.2 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 9.8 | |
| P/B | 10.8 | -138.7 | · | 49.5 | 68.5 | 11.0 | · | -2.9 | -25.5 | 15.9 | · | 5.3 | 3.4 | 4.4 | · | 5.5 | |
| P / Tangible Book | 10.8 | · | · | 49.5 | 68.5 | 11.0 | · | · | · | 15.9 | · | 5.3 | 3.4 | 4.4 | · | 5.5 | |
| P / Cash Flow | · | -17.1 | · | · | · | -9.7 | · | · | · | -6.4 | · | · | · | -21.6 | · | · | |
| Earnings Yield | -54.5% | -22.1% | · | -29.2% | -51.7% | -64.5% | · | 368.0% | 453.3% | 219.2% | · | -847.0% | -978.6% | -1957.9% | · | -495.8% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | · | · | $2M | $28M |
| Operating Margin % | · | · | · | · | -138.8% |
| Net Income | $-40M | $-52M | $-35M | $-28M | $-55M |
| Diluted EPS | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | · | · | · | 0.0 |
| Current Ratio | · | 1.8 | · | · | 8.1 |
| Quick Ratio | · | 1.5 | · | · | 7.9 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $-37M | · | · | $-53M |
Institutional owners (13F) 67 filers · $26.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
67
Value held
$26.7M
New positions
35
Exited positions
22
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 35 (+12 vs prior Q) | 22 (+15 vs prior Q) | 17 (+3 vs prior Q) | 6 (-2 vs prior Q) | +2.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Knoll Capital Management, LLC | $4,738,751 | 1,211,957 | 17.78% | Shares |
| VANGUARD GROUP INC | $3,955,331 | 496,901 | 14.84% | Shares |
| BlackRock, Inc. | $2,995,079 | 766,005 | 11.24% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $2,237,110 | 572,151 | 8.39% | Shares |
| Caption Management, LLC | $1,634,771 | 418,100 | 6.13% | Call option |
| GEODE CAPITAL MANAGEMENT, LLC | $1,217,614 | 311,354 | 4.57% | Shares |
| TORONTO DOMINION BANK | $782,000 | 200,000 | 2.93% | Call option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $709,274 | 181,400 | 2.66% | Call option |
| STATE STREET CORP | $701,532 | 179,420 | 2.63% | Shares |
| Caption Management, LLC | $647,887 | 165,700 | 2.43% | Put option |
| JANE STREET GROUP, LLC | $600,576 | 153,600 | 2.25% | Put option |
| CITADEL ADVISORS LLC | $524,722 | 134,200 | 1.97% | Call option |
| NORTHERN TRUST CORP | $508,933 | 130,162 | 1.91% | Shares |
| DIADEMA PARTNERS LP | $438,311 | 112,100 | 1.64% | Call option |
| Ikarian Capital, LLC | $418,761 | 107,100 | 1.57% | Call option |
| Ikarian Capital, LLC | $418,761 | 107,100 | 1.57% | Put option |
| Ikarian Capital, LLC | $391,000 | 100,000 | 1.47% | Shares |
| DIADEMA PARTNERS LP | $391,000 | 100,000 | 1.47% | Put option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $352,291 | 90,100 | 1.32% | Put option |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $347,619 | 88,905 | 1.30% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $344,322 | 88,062 | 1.29% | Shares |
| ALLIANCEBERNSTEIN L.P. | $317,805 | 81,280 | 1.19% | Shares |
| UBS Group AG | $158,039 | 40,419 | 0.59% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $126,684 | 32,400 | 0.48% | Call option |
| BOOTHBAY FUND MANAGEMENT, LLC | $126,684 | 32,400 | 0.48% | Put option |
| JANE STREET GROUP, LLC | $126,684 | 32,400 | 0.48% | Call option |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $123,970 | 31,706 | 0.47% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $119,998 | 30,690 | 0.45% | Shares |
| MORGAN STANLEY | $99,885 | 25,546 | 0.37% | Shares |
| Leonteq Securities AG | $78,200 | 20,000 | 0.29% | Shares |
| Nuveen, LLC | $69,942 | 17,888 | 0.26% | Shares |
| CITIGROUP INC | $69,309 | 17,726 | 0.26% | Shares |
| Bank of New York Mellon Corp | $62,107 | 15,884 | 0.23% | Shares |
| CITADEL ADVISORS LLC | $58,650 | 15,000 | 0.22% | Put option |
| NEW YORK STATE COMMON RETIREMENT FUND | $55,522 | 14,200 | 0.21% | Shares |
| MEYER HANDELMAN CO | $54,345 | 13,899 | 0.20% | Shares |
| HighTower Advisors, LLC | $53,434 | 13,666 | 0.20% | Shares |
| RAYMOND JAMES FINANCIAL INC | $49,735 | 12,720 | 0.19% | Shares |
| DEUTSCHE BANK AG\ | $49,469 | 12,652 | 0.19% | Shares |
| WELLS FARGO & COMPANY/MN | $46,228 | 11,823 | 0.17% | Shares |
| CIBC Private Wealth Group LLC | $42,560 | 7,000 | 0.16% | Shares |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $41,663 | 11,972 | 0.16% | Shares |
| HB Wealth Management, LLC | $40,910 | 10,463 | 0.15% | Shares |
| Summit Financial, LLC | $39,120 | 10,005 | 0.15% | Shares |
| Mayflower Financial Advisors, LLC | $39,100 | 10,000 | 0.15% | Shares |
| MOODY LYNN LIEBERSON & WALKER, LLC | $39,100 | 10,000 | 0.15% | Shares |
| &PARTNERS | $39,100 | 10,000 | 0.15% | Shares |
| RHUMBLINE ADVISERS | $26,119 | 6,681 | 0.10% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $23,331 | 5,967 | 0.09% | Shares |
| JPMORGAN CHASE & CO | $21,488 | 5,372 | 0.08% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| GKCC, LLC, Yekaterina Chudnovsky | June 4, 2025 | 48.00% | Amendment | · | SEC |
| Yekaterina Chudnovsky, GKCC, LLC ×6 filings | March 7, 2025 | 48.10% | Amendment | · | SEC |
| Access Industries Holdings LLC, Access Industries, LLC, Access Industries Management, LLC, Clal Industries Ltd., Clal Biotechnology Industries Ltd., Len Blavatnik ×5 filings | April 10, 2024 | · | Initial filing | · | SEC |
| Jay R. Venkatesan, M.D. | June 14, 2023 | · | Initial filing | M&A / sale | SEC |
| Jay R. Venkatesan | April 27, 2022 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 19 insiders · 8 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Robert Connelly | CEO, President and Director | July 16, 2026 A | 120,570 | 0 | 0 | $0 |
| Brian Piekos | Chief Financial Officer | Feb. 1, 2024 A | · | 0 | 0 | $0 |
| Gregory S Curhan | Chief Financial Officer | March 2, 2022 A | 4,000 | 0 | 0 | $0 |
| Peter Demuth | Chief Scientific Officer | July 16, 2026 A | 21,543 | 0 | 0 | $0 |
| Preetam Shah | Chief Strategy and Financial Officer | July 16, 2026 A | 24,000 | 0 | 0 | $0 |
| Christopher Haqq | Executive Vice President, Head of R&D and Chief Medical Officer | July 16, 2026 A | 57,381 | 0 | 0 | $0 |
| John F. Neylan | Executive Vice President, Chief Medical Officer and Head of Research | March 2, 2022 A | 35,136 | 0 | 0 | $0 |
| Jennifer J Rhodes | Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Secretary | March 2, 2022 A | 30,399 | 0 | 0 | $0 |
| Yekaterina Chudnovsky | Director | Aug. 31, 2026 A | · | 0 | 0 | $0 |
| Carol Gail Ashe | Director | Aug. 31, 2026 A | · | 0 | 0 | $0 |
| Allen Nissenson | Director | Aug. 31, 2026 A | 9,383 | 0 | 0 | $0 |
| Jay Venkatesan | Director | Aug. 31, 2026 A | 179,581 | 0 | 0 | $0 |
| Karen J Wilson | Director | Aug. 31, 2026 A | 18,718 | 0 | 0 | $0 |
| Julian Adams | Director | Aug. 31, 2026 A | · | 0 | 0 | $0 |
| Robert R Ruffolo | Director | Aug. 31, 2026 A | · | 0 | 0 | $0 |
| Itzhak Goldberg | Director | July 1, 2022 F | 1,687,986 | 0 | 0 | $0 |
| Victor F Ganzi | Director | June 9, 2022 A | 823,117 | 0 | 0 | $0 |
| Gilbert S Omenn | Director | June 9, 2022 A | 80,326 | 0 | 0 | $0 |
| EISA-ABC LLC | 10% owner | Aug. 31, 2021 J | 2,740,978 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 8 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.01% | 43,429 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.00% | 121,695 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.00% | 6,202 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.00% | 312,895 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 143,596 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 415,401 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 74,933 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 13,972 SH | Aug. 19, 2026 | Daily |
ELTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$10.00
+420.8%
3 30.0%
Strong Buy
5 50.0%
Buy
2 20.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-10-03Mean target $13.67 +611.8%
← Below all targets
Current price $1.92
Low$8.00
Mean$13.67
High$23.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026